Plus   Neg

BioMarin, DiNAQOR To Develop Gene Therapies For Rare Genetic Cardiomyopathies

BioMarin Pharmaceutical Inc. (BMRN) said Sunday that it has reached a preclinical collaboration and license agreement with DiNAQOR AG to develop novel gene therapies to treat rare genetic cardiomyopathies. The company did not disclose financial terms.

DiNAQOR will receive an undisclosed upfront payment and is eligible to receive development, regulatory and commercial milestones on product sales in addition to tiered royalties on worldwide sales.

BioMarin reiterated its 2020 GAAP net income guidance of $20 million to $80 million, inclusive of the collaboration.

The license initially covers DiNAQOR's lead program, DiNA-001 for MYBPC3 hypertrophic cardiomyopathy. Hypertrophic cardiomyopathy is one of the most common genetic heart diseases.

In addition, the companies will collaborate on several of DiNAQOR's other pipeline programs, and BioMarin has the option to extend the license to include these additional programs on similar terms.

BioMarin is simultaneously investing in DiNAQOR, reflecting the long-term commitment to the collaboration.

Hypertrophic cardiomyopathy affects the heart muscle, causing the muscle to enlarge.
Hypertrophic cardiomyopathy patients have an increased risk of developing heart failure and life-threatening arrhythmias.

There are no approved pharmacological treatment options available that address the underlying disease biology of Hypertrophic cardiomyopathy and invasive surgery or heart transplantation may be the only options available for patients with advanced disease.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Former Google engineer Anthony Levandowski was sentenced by a U.S. judge to eighteen months in prison for stealing trade secrets from Google's self-driving car unit before he defected to Uber's rival unit. Levandowski admitted that from 2009 to 2016, he worked in Google's self-driving car program, known then as Project Chauffer. JetBlue has strengthened its face covering policy, by prohibiting face masks with vents or exhalation valves, starting August 10. It will also no longer allow customers to claim exemptions from wearing a face covering altogether. Home Depot, Inc. is set to open three new distribution centers in Georgia over the next 18 months, which is expected to create an additional 1,000 new jobs in Greater Atlanta, including full-time and part-time positions. The home improvement retailer has already created more than 5,000 new jobs in Georgia over the last five years.
Follow RTT